AGIOS PHARMACEUTICALS INC (AGIO)
US00847X1046 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -352.64M | -352.09M | -231.80M | 1.60B | -327.37M | |||
| Depreciation Amortization | 6.17M | 6.62M | 8.56M | 9.24M | 9.98M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -22.24M | -19.06M | -16.43M | -36.82M | -71.04M | |||
| Taxes Paid | N/A | 1.57M | N/A | N/A | N/A | |||
| Other non cash items | 67.98M | 68.46M | -69.81M | -1.98B | 97.66M | |||
| OPERATING CASH FLOW | -300.73M | -296.06M | -309.48M | -407.32M | -290.76M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -740.00K | -999.00K | -4.88M | -5.74M | -14.91M | |||
| Other Investing Activity | 307.28M | 240.57M | 248.14M | 1.25B | 90.66M | |||
| INVESTING CASH FLOW | 306.54M | 239.57M | 243.26M | 1.25B | 75.75M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -330.00K | -580.00K | -340.00K | |||
| Stock Issued/Repurchased | 8.80M | 5.43M | 2.68M | -765.19M | 11.32M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 0.00 | 250.54M | |||
| FINANCING CASH FLOW | 8.80M | 5.43M | 2.35M | -765.77M | 261.52M | |||
| CHANGE IN CASH | 14.60M | -51.05M | -63.87M | 75.69M | 46.51M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -300.73M | -296.06M | -309.48M | -407.32M | -290.76M | |||
| Capital Expenditure | -740.00K | -999.00K | -4.88M | -5.74M | -14.91M | |||
| FREE CASH FLOW | -301.47M | -297.06M | -314.36M | -413.06M | -305.67M | |||
All data in USD